Key result
Annual V/Q scans decline while the proportion read by low-volume physicians rises to ~43%.
Observational
Yes
Answers are grounded in this paper and cite their sources.
V/Q scan utilization in the US Medicare population has declined significantly from 2013 to 2023, accompanied by an increase in the proportion of low-volume readers, raising concerns about diagnostic quality and access.
Ventilation-Perfusion (V/Q) scan has been established as a nuclear imaging modality for diagnosis of pulmonary embolism (PE), especially in patients with contraindications computed tomography pulmonary angiography (CTPA). However, its use in United States is declining. We analyzed national Medicare data (2013-2023) to assess V/Q and Q scan utilization and physician procedure volumes. Our analysis shows that annual V/Q scans have been declining over the period from 2013 to 2023, with a marked drop occurring between 2019 and 2020 (COVID-19 era). Most of the V/Q scans have been read by low volume readers (< 11/ year). Low-volume readers percentage increased from 20.3% in 2013 to 43.4% in 2023. These trends may impact diagnostic quality and highlight the need to reassess training, competency, and access to V/Q imaging for patients contraindicated for CTPA.
No takes yet. Share an insight, caveat, or question.
Ghazawi et al. (2026) conducted an observational in Pulmonary embolism. Ventilation-Perfusion (V/Q) scan was evaluated on V/Q and Q scan utilization and physician procedure volumes. Annual V/Q scans in the United States declined from 2013 to 2023, while the percentage of scans read by low-volume readers (<11/year) increased from 20.3% to 43.4%.
Synapse has enriched 10 related papers. Consider them for comparative context: